Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports

Joost J. Enzing^*
, Saskia Knies
, Jop Engel
, Maarten J. IJzerman
, Beate Sander
, Rick Vreman
, Bert Boer
, Werner B.F. Brouwer

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

42 Downloads (Pure)

1 results
- Title
- Start date(ascending)

Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports
Enzing, J. J. (Creator), Knies, S. (Creator), Engel, J. (Creator), IJzerman, M. J. (Creator), Sander, B. (Creator), Vreman, R. (Creator), Boer, B. (Creator) & Brouwer, W. (Creator), 2022
DOI: 10.6084/m9.figshare.c.6175745.v1, https://springernature.figshare.com/collections/Do_Health_Technology_Assessment_organisations_consider_manufacturers_costs_in_relation_to_drug_price_A_study_of_reimbursement_reports/6175745/1
Dataset